Laurion Capital Management LP Pyxis Oncology, Inc. Transaction History
Laurion Capital Management LP
- $3.86 Billion
- Q1 2025
A detailed history of Laurion Capital Management LP transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 3,625,974 shares of PYXS stock, worth $4.13 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,625,974
Previous 3,625,974
-0.0%
Holding current value
$4.13 Million
Previous $5.62 Million
36.78%
% of portfolio
0.09%
Previous 0.11%
Shares
5 transactions
Others Institutions Holding PYXS
# of Institutions
92Shares Held
23.2MCall Options Held
138KPut Options Held
30.9K-
Black Rock Inc. New York, NY2.79MShares$3.18 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.49MShares$2.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.44MShares$2.78 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.11MShares$1.26 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.1MShares$1.25 Million0.07% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $40M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...